AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage clinical trial.
A keenly-watched COVID-19 vaccine will be priced to allow as wide as possible access to it, if it proves successful, and will be made at huge scale to keep costs down and supply up, said the Oxford University professor co-leading its development. Emer McCarthy reports.
Home Minister Shah on July 12 at tree plantation drive of Central Armed Police Forces in Gurugram praised security forces for their efforts in COVID battle. "India is one of the most populous countries. Everyone thought how will a country like India battle COVID19, there were apprehensions but today the whole world is witnessing how one of the most successful battles against COVID19 has been fought here," said Union Home Minister Amit Shah."In India's battle against COVID19, all of our security forces are playing a huge role, nobody can deny it. Today, I salute these corona warriors. They have proved that they not only know how to fight terrorism but also against COVID with help of people," he further added. Union Home Minister Amit Shah participated in the 'All India Tree Plantation Campaign' run by the Central Armed Police Forces in Gurugram.
Hyderabad-based entrepreneur Arun Varma, has developed 'covidbedavailability.in', a software to help COVID-19 patients to locate hospitals with bed availability. He said, "This solution is designed for Govt to run their war rooms, control rooms and hospitals." Objective behind the development was to help patients to easily access information. A total of 32,224 confirmed cases have been recorded in Telangana so far.
Legendary actor Amitabh Bachchan is stable with mild symptoms and is currently admitted in the isolation unit of the Nanavati Super Speciality Hospital. He tested positive for COVID-19 yesterday. His son and actor Abhishek Bachchan also tested positive.
CNN reports that Malala Yousafzai, has graduated from Oxford University. She and her family celebrated, with cake and confetti. Malala, is a 22-year-old Nobel Peace Prize winner, who lived after being shot in the head at 15 by the Taliban. Born in Pakistan, Malala is an activist who speaks out about girls education and human rights. On Friday Malala tweeted, "Hard to express my joy and gratitude right now as I completed my Philosophy, Politics and Economics degree at Oxford.
Protesters in Oxford demanded the removal of a statue of colonialist Cecil Rhodes, while in London, a slave-trader's statue was targeted as part of protests against symbols of the slave trade and empire.
U.S. Health and Human Services Secretary Alex Azar on Thursday disputed whistleblower Richard Bright's testimony before a House of Representatives panel about the Trump administration's response to the coronavirus pandemic.
Dramatic testimony is expected Thursday from an ousted health official who has accused the Trump administration of downplaying the coronavirus threat - and says he was pushed out when he voiced concerns. Lisa Bernhard has more.
The corporation behind Johnson's, Neutrogena, Clean & Clear, and more has just vowed to stop selling two lines of skin-care products used for skin-lightening overseas. On June 19, in the wake of the recent Black Lives Matter uprising, Johnson & Johnson said that it will cease production of two different lines from Asian and Middle Eastern markets that were used for skin-lightening lines.
Johnson & Johnson plans to start testing its coronavirus vaccine candidate in humans in July. The company said it will move up the timeline by about two months to start clinical trials. Previously the aim was to enter the clinic with the vaccine in September. The study will start in the second half of July and enroll 1,045 healthy volunteers in the US and Belgium. If the vaccine works, Johnson & Johnson has already pledged to distribute it at a nonprofit rate to help end the pandemic.
Johnson & Johnson is the world's largest health care company. Business Insider reports that the company plans to start testing its coronavirus vaccine candidate in humans in July. On Wednesday, Johnson & Johnson it will move up the timeline by about two months to start clinical trials. It was previously aiming for trials in September. 1,045 healthy volunteers in the US and Belgium will join the study, which starts in July.
U.S. stocks posted gains Monday as signs of U.S. economic recovery helped offset jitters over increasingly violent social unrest amid an ongoing pandemic and rising U.S.-China tensions. Fred Katayama reports.